| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | 19FUJ2C58T |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Sleep Wake Disorders | 3 | D012893 | ClinicalTrials |
| Vestibular Neuronitis | 3 | D020338 | ClinicalTrials |
| Memory Disorders | 3 | D008569 | ClinicalTrials |
| Ischemic Stroke | 2 | D000083242 | ClinicalTrials |
| Alzheimer Disease | 2 | D000544 | ClinicalTrials |
| Parkinson Disease | 2 | D010300 | ClinicalTrials |
| Sexual Dysfunction, Physiological | 2 | D012735 | ClinicalTrials |
| Friedreich Ataxia | 2 | D005621 | ClinicalTrials |
| Glaucoma, Open-Angle | 2 | D005902 | ClinicalTrials |
| Skin Diseases | 1 | D012871 | ClinicalTrials |
| Multiple Sclerosis | 1 | D009103 | ClinicalTrials |
| Vitiligo | 1 | D014820 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 1 | D003924 | ClinicalTrials |
| Retinitis Pigmentosa | 0 | D012174 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108466 |
| FDA SRS | 19FUJ2C58T |
CONTENTS